These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 36065731)
1. Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome. Torumkuney D; Kundu S; Vu GV; Nguyen HA; Pham HV; Kamble P; Truong Ha Lan N; Keles N J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i26-i34. PubMed ID: 36065731 [TBL] [Abstract][Full Text] [Related]
2. Country data on AMR in Russia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. Torumkuney D; Kozlov R; Sidorenko S; Kamble P; Lezhnina M; Galushkin A; Kundu S J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i61-i69. PubMed ID: 36065732 [TBL] [Abstract][Full Text] [Related]
3. Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. Torumkuney D; Nijhara P; Beltrame CO; Baisch EQ; Ferreira RM J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i35-i42. PubMed ID: 36065730 [TBL] [Abstract][Full Text] [Related]
4. Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. Torumkuney D; Jamil B; Nizamuddin S; van Hasselt J; Pirzada U; Manenzhe R J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i18-i25. PubMed ID: 36065729 [TBL] [Abstract][Full Text] [Related]
5. Country data on AMR in Mexico in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. Torumkuney D; de la Torre C; Langfeld K; Lopez-Turrent NP; Ossaille Beltrame C J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i43-i50. PubMed ID: 36065728 [TBL] [Abstract][Full Text] [Related]
6. Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. Torumkuney D; Poojary A; Shenoy B; Nijhara P; Dalal K; Manenzhe R J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i10-i17. PubMed ID: 36065726 [TBL] [Abstract][Full Text] [Related]
7. Country data on AMR in Türkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. Torumkuney D; Aktas Z; Unal S; van Hasselt J; Seyhun Y; Keles N J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i51-i60. PubMed ID: 36065733 [TBL] [Abstract][Full Text] [Related]
8. Country data on AMR in Kuwait in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. Torumkuney D; Behbehani N; van Hasselt J; Hamouda M; Keles N J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i77-i83. PubMed ID: 36065725 [TBL] [Abstract][Full Text] [Related]
9. Country data on AMR in Saudi Arabia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. Torumkuney D; Dolgum S; van Hasselt J; Abdullah W; Keles N J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i70-i76. PubMed ID: 36065727 [TBL] [Abstract][Full Text] [Related]
10. Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022. Cantón R; Akova M; Langfeld K; Torumkuney D J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i2-i9. PubMed ID: 36065724 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15. Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578 [TBL] [Abstract][Full Text] [Related]
12. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Pfaller MA; Ehrhardt AF; Jones RN Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion. Bizri AR; El-Fattah AA; Bazaraa HM; Al Ramahi JW; Matar M; Ali RAN; El Masry R; Moussa J; Abbas AJA; Aziz MA PLoS One; 2023; 18(7):e0288550. PubMed ID: 37498951 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program. Gordon KA; Biedenbach DJ; Jones RN Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469 [TBL] [Abstract][Full Text] [Related]
17. Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Torumkuney D; Van PH; Thinh LQ; Koo SH; Tan SH; Lim PQ; Sivhour C; Lamleav L; Somary N; Sosorphea S; Lagamayo E; Morrissey I J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i19-i42. PubMed ID: 32337597 [TBL] [Abstract][Full Text] [Related]
18. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections. Ehrhardt AF; Russo R Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441 [TBL] [Abstract][Full Text] [Related]
19. Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam. Van PH; Binh PT; Minh NH; Morrissey I; Torumkuney D J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i93-102. PubMed ID: 27048586 [TBL] [Abstract][Full Text] [Related]
20. Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey. Torumkuney D; Gur D; Soyletir G; Gurler N; Aktas Z; Sener B; Tunger A; Bayramoglu G; Koksal I; Yalcin AN; Tanriver Y; Morrissey I; Barker K J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i85-91. PubMed ID: 27048585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]